# Altria Group financial performance and outlook

> Developing situation record from CLSTR: https://clstr.news/situations/altria-group-financial-performance-and-outlook
> Updated: 2026-10-27T17:30:00.000Z. Sources: 4. Developments: 2.

Altria Group, the largest tobacco company in the United States, is facing scrutiny regarding its stock price and upcoming financial reports. Following a ‘sell’ rating from Barclays, which set a price target of 58.00 US dollars, the company’s stock closed at 73.62 US dollars on October 26, 2026.

As the company prepares to report quarterly earnings, analysts anticipate a year-on-year revenue growth of 1.2%, a potential reversal from the 1.7% decrease seen in the same quarter the previous year. While Altria has missed Wall Street revenue estimates multiple times over the last two years, it has maintained its status as a ‘Dividend King’ by increasing payouts for 57 consecutive years.

To address declining adult smoking rates and reduce dependence on traditional cigarettes, Altria is expanding its smoke-free portfolio, including NJOY e-cigarettes and On nicotine pouches, with a target of achieving at least $5 billion in smoke-free revenue by 2028.

## Timeline

### 2026-10-27: Altria prepares to report quarterly earnings

Altria Group is set to report quarterly earnings with analysts projecting 1.2% year-on-year revenue growth.

2 sources. https://clstr.news/cluster/altria-prepares-to-report-quarterly-earnings

### 2026-10-27: Financial updates for Albemarle, Raymond James, and Altria Group

Albemarle announced a 0.41 USD dividend, Raymond James achieved a sixth record fiscal year, and Barclays maintained a sell rating on Altria Group.

2 sources. https://clstr.news/cluster/financial-updates-for-albemarle-raymond-james-and-altria-group

---
Cite as: Altria Group financial performance and outlook. CLSTR, https://clstr.news/situations/altria-group-financial-performance-and-outlook